About MX Orthopedics
MX Orthopedics is a Healthcare company based in Cambridge (United States) founded in 2008, and was acquired by Arthrex in July 2016. It operates as a nitinol-based hip implants for fracture fixation are developed. MX Orthopedics has raised $4.48 million across 3 funding rounds from investors including Arthrex. The company has 5 employees. The company was acqui-hired. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
MX Orthopedics was founded in 2008 and is based in Cambridge, United States. Operations focus on the medical device sector, where superelastic nitinol alloy is used to create hip implant devices. The dynaMö product line encompasses compression screws, plates, staples, malleable bridge staples, and intramedullary implants designed for fracture fixation. Compressive forces are generated and maintained by these foreshortening implants, which are noted for biocompatibility.
- Headquarters Cambridge, United States
- Employees 5
- Stage Acquired
- SectorsHealthcare
- Website mxortho.com
- Social LinkedIn
- Acquired by Arthrex (Jul 2016)
Funding Insights of MX Orthopedics
MX Orthopedics has successfully raised a total of $4.48M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.06 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.48M
- Total Rounds 3
- Last Round Series A — $2.06M
- First Round $1M
(Oct 2011)
All 3 funding rounds of MX Orthopedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | $2.06M | Series A | – | – | – |
| Sep 2013 | $1.42M | Seed | – | – | – |
| Oct 2011 | $1M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in MX Orthopedics
MX Orthopedics has secured backing from 1 investor. Prominent investors backing the company include Arthrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Orthopedic devices and arthroscopy education are developed by Arthrex. | 1981 | arthrex.com | Naples, United States |
Investor details for MX Orthopedics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MX Orthopedics
4 dated milestones of MX Orthopedics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded MX Orthopedics is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series A, of $2.1M.
- Exit Acquired by Arthrex.
Competitors of MX Orthopedics
MX Orthopedics has 9 listed competitors in our database, 7 of them funded. They include Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| treace.com | 2013 | Ponte Vedra Beach, United States | $15M | 516 | Orthopedic foot and ankle correction systems are developed and offered. | |
| bioretec.com | 1985 | Tampere, Finland | $8.58M | – | Provider of bioabsorbable, bioactive and drug-releasing surgical implants | |
| lociorthopaedics.com | 2017 | Galway, Ireland | $23.06M | – | Thumb implant for thumb base arthritis | |
| illuminoss.com | 2007 | East Providence, United States | $62.47M | 21 | Minimally invasive orthopedic systems for bone fracture stabilization are developed. | |
| stanmoreimplants.com | 1948 | Elstree, United Kingdom | $6.44M | 126 | Modular implants for limb sparing and complex primary and revision joint replacement | |
| medartis.com | 1997 | Basel, Switzerland | – | – | Metal implants for orthopedic fracture fixation are developed and marketed. | |
| intellijointsurgical.com | 2010 | Waterloo, Canada | $24.68M | 49 | Developer of 3D surgical navigation tools for hip and knee replacements | |
| atreonortho.com | 2016 | Hilliard, United States | $3.83M | – | Scaffold-based products are developed for soft tissue injury repair. | |
| biomet.com | 1977 | Warsaw, United States | – | 3,664 | Orthopedic surgical and non-surgical products are designed and distributed. |
Detailed competitors of MX Orthopedics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as MX Orthopedics (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MX Orthopedics
MX Orthopedics was founded in 2008 and raised its 1st funding round 3 years after it was founded.
MX Orthopedics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
MX Orthopedics is a funded company, having raised a total of $4.48M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Oct 2011.
MX Orthopedics has 5 employees.
MX Orthopedics was founded in 2008 and is based in Cambridge, United States. Operations focus on the medical device sector, where superelastic nitinol alloy is used to create hip implant devices. The dynaMö product line encompasses compression screws, plates, staples, malleable bridge staples, and intramedullary implants designed for fracture fixation. Compressive forces are generated and maintained by these foreshortening implants, which are noted for biocompatibility.
MX Orthopedics's top competitors include Treace Medical Concepts, Loci Orthopaedics and Bioretec.
MX Orthopedics has 1 investor. Key investors include Arthrex.
Yes. MX Orthopedics was acquired by Arthrex in July 2016.